Global Clinical Trial Imaging Market Research Report 2022-2030 – Key Players Developing CTI Services for Oncology, Neurology and Musculoskeletal Applications –

DUBLIN–(BUSINESS WIRE)–The “Analysis Report of Clinical Trial Imaging Market Size, Share and Trends by Services (Clinical Trial Design and Consulting Services, Reading and Analytics Services), By End Use , by Application, by Region and Segment Forecast, 2022-2030″ report has been added to from offer.

The global clinical trial imaging market is expected to reach USD 1.97 billion by 2030 growing at a CAGR of 8.7%.

Rising expenditure on research and development to discover new drugs and therapies to treat chronic diseases is propelling the growth of the industry. The images obtained from the internal examination of the body are used to determine the activity of the drug. Clinical trial imaging allows rapid, detailed and accurate screening. The need for imaging for clinical trials is rapidly increasing in all phases of trials. Medical imaging in clinical trials is used as a primary, quantitative and surrogate biomarker.

The design of the clinical trial includes the selection of the patient population, the stratification based on biomarkers, different methods of assigning treatments, the choice of effective and reliable endpoints and the validation of endpoints of substitution, sample size calculation, trial simulations, adaptive trial setup, statistical and interim analysis, and assisting customers in dealing with regulatory authorities such as the EMA and FDA to discuss study design or defend study results.

Market players provide analytical testing services, pharmacokinetics, reading and pharmacodynamics services for enhanced clinical development. IXICO offers cutting-edge technologies to catalyze clinical trials in neuroscience. The company’s imaging biomarkers help measure the safety and effectiveness of therapies used for neuroimaging. Imaging biomarkers are effective in radiological readings. This enables the reading of MRIs for the central neuro to improve continuous monitoring assessment of drug safety and subject eligibility

Report Highlights

  • Project and data management services held the largest share in 2021 due to growing data management and workflow needs for clinical trial imaging.

  • Operational imaging services occupied a significant share in 2021 and include imaging modalities such as MRI, CT scan, ultrasound, optical coherence tomography (OCT), X-ray and others.

  • The CT Scan modality held the largest share in 2021 due to its non-invasive nature and ability to provide detailed disease information for improved treatment.

  • The other application segment held the largest share in 2021. This segment includes oncology, neurology, and musculoskeletal. Market players such as ICON, Bioclinica, Navitas Life Sciences and Paraxel International are developing their clinical trial imaging services for these applications.

  • CROs held the largest share in 2021 due to increased investment in research and development, the snowball effect of pharmaceutical and biotechnology companies outsourcing activities to reduce costs and deadlines, and expiration of patents.

  • North America dominated this market with the largest share in 2021 owing to the increase in the geriatric population, along with chronic diseases and growing demand for treatment options.

Market dynamics

  • Drivers

    • Growing number of pharmaceutical and biotech companies

    • Growing number of contract research organizations

    • Increase investment in research and development

  • Constraints

    • High cost of machines and installations

Segments Covered

  1. Service estimates and trend analysis

  2. Application estimates and trend analysis

  3. End-use estimates and trend analysis

  4. Regional estimates and trend analysis

Profiled companies

  • Ixico plc

  • Navitas life sciences

  • Resonance Health

  • Proscan Imaging

  • Radiant Sage LLC

  • Medpace

  • Biomedical Systems Corp.

  • Cardiovascular Imaging Technologies

  • Intrinsic imaging

  • BioTelemetry

For more information on this report, visit

Comments are closed.